Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2. (Q34511480)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2. |
scientific article |
Statements
1 reference
Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2. (English)
1 reference
1 reference
T Safra
1 reference
S Jeffers
1 reference
D D Tsao-Wei
1 reference
S Groshen
1 reference
O Lyass
1 reference
R Henderson
1 reference
G Berry
1 reference
A Gabizon
1 reference
1 August 2000
1 reference
1 reference
11
1 reference
8
1 reference
1029-1033
1 reference
Identifiers
1 reference
1 reference